Literature DB >> 35727357

The neural signatures of psychoses in Alzheimer's disease: a neuroimaging genetics approach.

Riccardo Manca1, Antonio F Pardiñas2, Annalena Venneri3,4.   

Abstract

Psychoses in Alzheimer's disease (AD) are associated with worse prognosis. Genetic vulnerability for schizophrenia (SCZ) may drive AD-related psychoses, yet its impact on brain constituents is still unknown. This study aimed to investigate the association between polygenic risk scores (PRSs) for SCZ and psychotic experiences (PE) and grey matter (GM) volume in patients with AD with (AD-PS) and without (AD-NP) psychosis. Clinical, genetic and T1-weighted MRI data for 800 participants were extracted from the ADNI database: 203 healthy controls, 121 AD-PS and 476 AD-NP. PRSs were calculated using a Bayesian approach and analysed at ten p-value thresholds. Standard voxel-based morphometry was used to process MRI data. Logistic regression models including both PRSs for SCZ and PE, and an AD-PRS were used to predict psychosis in AD. Associations between PRSs and GM volume were investigated in the whole sample and the three groups independently. Only the AD-PRS predicted psychosis in AD. Inconsistent associations between the SCZ-PRS and PE-PRS and GM volumes were found across groups. The SCZ-PRS was negatively associated with medio-temporal/subcortical volumes and positively with medial/orbitofrontal volumes in the AD-PS group. Only medio-temporal areas were more atrophic in the AD-PS group, while there was no significant correlation between psychosis severity and GM volume. Although not associated with psychoses, the SCZ-PRS was correlated with smaller medio-temporal and larger orbitofrontal volumes in AD-PS. Similar alterations have also been observed in SCZ patients. This finding suggest a possible disconnection between these regions associated with psychoses in more advanced AD.
© 2022. The Author(s).

Entities:  

Keywords:  Dementia; Disconnection; Neuropsychiatric; Orbitofrontal; Polygenic risk; Schizophrenia

Year:  2022        PMID: 35727357     DOI: 10.1007/s00406-022-01432-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  56 in total

1.  Delusions in Alzheimer Disease are Associated With Decreased Default Mode Network Functional Connectivity.

Authors:  Winnie Qian; Corinne E Fischer; Nathan W Churchill; Sanjeev Kumar; Tarek Rajji; Tom A Schweizer
Journal:  Am J Geriatr Psychiatry       Date:  2019-04-03       Impact factor: 4.105

2.  Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.

Authors:  Michael H Connors; David Ames; Michael Woodward; Henry Brodaty
Journal:  Am J Geriatr Psychiatry       Date:  2017-10-20       Impact factor: 4.105

3.  "Noncognitive" symptoms of early Alzheimer disease: a longitudinal analysis.

Authors:  Mary Clare Masters; John C Morris; Catherine M Roe
Journal:  Neurology       Date:  2015-02-10       Impact factor: 9.910

4.  Cerebral correlates of psychotic symptoms in Alzheimer's disease.

Authors:  M S Mega; L Lee; I D Dinov; F Mishkin; A W Toga; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

5.  Are the behavioral symptoms of Alzheimer's disease directly associated with neurodegeneration?

Authors:  Laura Serra; Roberta Perri; Mara Cercignani; Barbara Spanò; Lucia Fadda; Camillo Marra; Giovanni A Carlesimo; Carlo Caltagirone; Marco Bozzali
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Longitudinal relationships between Alzheimer disease progression and psychosis, depressed mood, and agitation/aggression.

Authors:  Laura B Zahodne; Katherine Ornstein; Stephanie Cosentino; D P Devanand; Yaakov Stern
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-17       Impact factor: 4.105

7.  Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Aaron M Tetreault; Tony Phan; Dana Orlando; Ilwoo Lyu; Hakmook Kang; Bennett Landman; R Ryan Darby
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

8.  Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.

Authors:  Jeremy Koppel; Chris Acker; Peter Davies; Oscar L Lopez; Heidy Jimenez; Miriam Azose; Blaine S Greenwald; Patrick S Murray; Caitlin M Kirkwood; Julia Kofler; Robert A Sweet
Journal:  Neurobiol Aging       Date:  2014-03-06       Impact factor: 4.673

9.  Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.

Authors:  Corinne E Fischer; Zahinoor Ismail; James M Youakim; Byron Creese; Sanjeev Kumar; Nicolas Nuñez; R Ryan Darby; Antonella Di Vita; Fabrizia D'Antonio; Carlo de Lena; William J McGeown; Ravona Ramit; Jill Rasmussen; Joanne Bell; Huali Wang; Marie-Andrée Bruneau; Peter K Panegyres; Krista L Lanctôt; Luis Agüera-Ortiz; Constantine Lyketsos; Jeffrey Cummings; Dilip V Jeste; Mary Sano; D P Devanand; Robert A Sweet; Clive Ballard
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  Hyperphosphorylated tau is elevated in Alzheimer's disease with psychosis.

Authors:  Patrick S Murray; Caitlin M Kirkwood; Megan C Gray; Kenneth N Fish; Milos D Ikonomovic; Ronald L Hamilton; Julia K Kofler; William E Klunk; Oscar L Lopez; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.